WinRevair’s Phase 3 HYPERION trial was stopped early for efficacy, with positive top-line results announced in the month ...

Spot charter rates secured — To date in Q3 2025, Suezmax spot rates are at $31,400 per day and Aframax/LR2 rates are at ...

Cash from operations— $36 million cash from operations for Q2 2025, exceeded guidance due to favorable cash collection, lower ...

Q2 2025 Earnings Conference Call August 4, 2025 1:30 PM ETCompany ParticipantsDaniel Patrick Penberthy - President ...

IDEXX Laboratories, Inc. ( NASDAQ: IDXX) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Andrew Emerson - Executive VP, CFO & Treasurer Jonathan J. Mazelsky - President, CEO & Director ...

Q2 2025 Earnings Call Transcript July 31, 2025 Grab Holdings Limited reports earnings inline with expectations. Reported EPS ...